viral
infect
long
suspect
play
role
pathogenesi
multipl
sclerosi
present
studi
two
differ
rodent
model
experiment
autoimmun
encephalomyel
eae
use
demonstr
abil
murin
exacerb
develop
neurolog
symptom
sjl
mice
receiv
uvinactiv
intranas
follow
immun
proteolipidprotein
peptid
infect
mice
becam
moribund
within
day
postimmun
wherea
mice
expos
uvinactiv
recov
second
model
lewi
rat
expos
uvinactiv
follow
passiv
transfer
encephalitogen
lymphocyt
specif
myelin
basic
protein
consist
infect
rat
higher
clinic
score
result
observ
acut
latent
infect
unlik
exacerb
due
signific
viral
replic
within
central
nervou
system
sinc
nest
pcr
viral
plaqu
assay
infectiouscent
assay
demonstr
detect
viru
spinal
cord
brain
infect
rodent
undergo
eae
taken
togeth
studi
demonstr
increas
clinic
symptom
eae
rodent
infect
gammaherpesviru
limit
abil
invad
central
nervou
system
suggest
multipl
sclerosi
ms
develop
patient
genet
predispos
demyelin
diseas
follow
exposur
environment
factor
strike
epidemiolog
evid
suggest
environment
factor
play
role
develop
ms
factor
includ
geograph
variat
preval
alter
suscept
follow
reloc
discord
clinic
diseas
major
monozygot
twin
howev
possibl
defin
exactli
environment
factor
associ
genet
predisposit
result
develop
clinic
diseas
forefront
list
possibl
environment
factor
might
exacerb
develop
sever
ms
viral
infect
fact
theilersviru
infect
central
nervou
system
cn
wide
use
mous
model
experiment
autoimmun
encephalomyel
eae
consist
reproduc
symptomolog
human
diseas
coronavirusmurin
hepat
viru
also
shown
caus
demyelin
diseas
cn
recent
studi
suggest
associ
infect
human
gammaherpesviru
ebv
risk
ms
one
prospect
epidemiolog
studi
antiebv
antibodi
level
elev
women
ms
suggest
ebv
might
involv
etiolog
autoimmun
diseas
recent
work
support
previou
studi
demonstr
increas
antiebv
antibodi
titer
patient
ms
addit
particular
cell
receptor
ms
patient
recogn
myelinbasicprotein
peptid
peptid
deriv
ebv
protein
studi
suggest
mechan
molecular
mimicri
might
facilit
develop
ms
time
ebv
infect
fig
sjl
mice
infect
show
increas
clinic
score
weight
loss
immunizationinduc
eae
group
sjl
mice
expos
uvinactiv
close
squar
infect
close
circl
day
prior
immun
plp
peptid
control
mice
close
triangl
infect
immun
irrelev
peptid
arrow
indic
day
immun
ie
day
follow
immun
mice
score
daili
presenc
clinic
symptom
result
present
mean
clinic
score
standard
deviat
indic
time
postimmun
b
mice
weigh
daili
percent
decreas
bodi
weight
determin
result
present
mean
bodi
weight
standard
deviat
asterisk
indic
signific
differ
p
x
compar
mice
versu
mice
treat
uvinactiv
studi
repres
three
separ
experi
direct
relationship
viral
infect
develop
ms
difficult
prove
relianc
human
autopsi
materi
materi
taken
blood
spinal
fluid
circumv
limit
rodent
model
ms
develop
contribut
greatli
understand
cellular
molecular
event
occur
demyelin
diseas
cn
relaps
eae
thelpercelland
macrophagemedi
diseas
character
inflamm
demyelin
within
cn
sjl
mous
often
use
model
diseas
activ
immun
immunodomin
peptid
proteolipid
protein
plp
induc
relaps
eae
mice
eae
also
induc
passiv
transfer
encephalitogen
lymphocyt
certain
strain
mice
rat
passiv
transfer
antigenspecif
helper
cell
obviat
need
activ
immun
mice
allow
studi
postimmun
event
develop
eae
passiv
transfer
encephalitogen
lymphocyt
lewi
rat
provid
reproduc
nonrelaps
form
eae
use
investig
acut
form
diseas
present
studi
immunizationinduc
eae
sjl
mice
passivetransferinduc
eae
lewi
rat
use
model
address
whether
infect
murin
could
exacerb
clinic
diseas
use
mous
model
ebv
human
infect
wellcharacter
rodent
model
studi
gammaherpesvirus
studi
present
rodent
expos
uvinactiv
infect
undergo
eae
score
sever
diseas
result
studi
clearli
demonstr
infect
murin
gammaherpesviru
exacerb
clinic
symptom
associ
eae
without
substanti
entri
viru
cn
follow
immun
sjl
mice
plp
peptid
neurodegen
diseas
ensu
follow
score
clinic
symptom
shown
fig
close
squar
day
follow
initi
immun
group
sjl
mice
previous
expos
uvinactiv
began
show
sign
cn
diseas
peak
day
kinet
magnitud
respons
similar
previous
report
other
contrast
clinic
score
sjl
mice
infect
dramat
differ
kinet
magnitud
fig
close
circl
compar
group
mice
expos
uvinactiv
clinic
symptom
infect
mice
began
day
earlier
result
mice
moribund
day
postimmun
clearli
mice
infect
immun
plp
peptid
demonstr
mark
exacerb
clinic
symptom
compar
control
control
demonstr
antigenspecif
natur
eae
induct
sever
group
mice
use
includ
group
mice
infect
given
complet
freund
adjuv
alon
given
pertussi
toxin
alon
immun
irrelev
peptid
none
mice
control
group
show
neurolog
deficit
cours
studi
eg
fig
close
triangl
absenc
detect
viral
dna
cn
sjl
mice
undergo
clinic
eae
group
sjl
mice
expos
uvinactiv
infect
nonimmun
eae
immun
induc
eae
eae
indic
mice
expos
uvinactiv
infect
nonimmun
kill
day
postinfect
repres
peak
leukocytosi
mice
infect
immun
induc
eae
kill
day
postinfect
mice
clinic
score
mice
kill
tissu
spleen
spinal
cord
taken
dna
extract
pcr
amplifi
gene
encod
number
pcr
cycl
use
amplif
indic
result
present
amplifi
pcr
product
electrophores
ethidiumbromidestain
agaros
gel
studi
perform
twice
similar
result
mice
kill
day
postinfect
mice
clinic
score
tissu
spleen
spinal
cord
taken
cell
isol
tissu
use
quantifi
amount
latent
viru
use
infectiouscent
assay
result
present
mean
viru
count
per
cell
standard
deviat
score
x
indic
presenc
latent
viru
level
detect
assay
studi
perform
twice
similar
result
addit
assess
clinic
diseas
decreas
bodi
weight
follow
mice
expos
uvinactiv
infect
immun
induc
eae
fig
show
earli
exacerb
weight
loss
mice
infect
viru
compar
mice
expos
uvinactiv
addit
histolog
analys
perform
indic
level
inflamm
spinal
cord
cerebellum
infect
versu
uninfect
mice
undergo
eae
day
postimmun
group
mice
kill
spinal
cord
cerebellum
stain
score
infiltr
leukocyt
mice
infect
significantli
p
x
inflamm
mean
score
mice
expos
uvinactiv
mean
score
wherea
control
mice
infect
immun
detect
inflamm
cn
mean
score
one
possibl
explan
exacerb
eae
would
replic
viru
within
cn
directli
caus
neuron
death
caus
destruct
inflammatori
respons
gain
access
cn
clinic
eae
presenc
viru
difficult
detect
address
whether
present
cn
sensit
nest
pcr
procedur
perform
detect
presenc
dna
encod
spleen
spinal
cord
infect
mice
infect
mice
undergo
clinic
eae
fig
show
result
one
pcr
viral
genom
easili
detect
peripher
lymphoid
organ
ie
spleen
spinal
cord
infect
mice
true
even
nest
pcr
perform
cycl
wherea
viral
dna
sequenc
abund
spleen
use
pcr
cycl
although
qualit
differ
viral
genom
presenc
cn
versu
peripher
lymphoid
organ
suggest
minim
viral
replic
latenc
occur
cn
directli
address
presenc
replic
viru
spleen
cn
infect
mice
undergo
clinic
eae
viralplaqu
assay
perform
plaqueform
assay
consist
fail
demonstr
presenc
lytic
viru
tissu
homogen
brain
spinal
cord
infect
mice
undergo
clinic
eae
regardless
timepoint
chosen
analysi
addit
infectiouscent
assay
use
quantifi
latent
viru
present
spleen
infect
sjl
mice
fig
show
similar
number
infecti
center
splenic
leukocyt
mice
whether
eae
induc
howev
unabl
detect
latent
cell
isol
spinal
cord
mice
fig
taken
togeth
result
fig
strongli
argu
presenc
signific
viral
burden
peripher
tissu
cn
passiv
transfer
encephalitogen
lymphocyt
lewi
rat
also
use
model
investig
abil
gammaherpesviru
exacerb
autoimmun
diseas
cn
howev
first
import
demonstr
strain
suscept
viral
infect
sinc
report
date
demonstr
infect
rat
follow
intranas
inocul
group
lewi
rat
plaqueform
unit
pfu
viru
characterist
splenomegali
leukocytosi
establish
latent
viru
observ
infect
rat
typic
spleen
infect
rat
increas
size
threefold
compar
rat
expos
uvinactiv
mg
versu
mg
respect
splenic
leukocyt
number
peak
day
postinfect
fig
presenc
viral
genom
easili
detect
rat
use
nest
pcr
fig
amplifi
product
absent
control
rat
addit
viral
latenc
establish
rat
highest
level
viral
burden
observ
day
postinfect
fig
previous
observ
laboratori
other
infecti
center
due
presenc
latent
viru
lytic
replic
viru
mechan
disrupt
splenocyt
produc
pfu
incub
permiss
monolay
cell
taken
togeth
result
demonstr
murin
infect
rat
induc
symptom
mononucleosislik
diseas
similar
seen
mice
hallmark
leukocytosi
establish
latenc
establish
characterist
infect
lewi
rat
induc
eae
anim
use
passiv
transfer
encephalitogen
lymphocyt
studi
group
rat
expos
uvinactiv
infect
intranas
infect
encephalitogen
lymphocyt
specif
myelin
basic
protein
given
intraven
rat
score
daili
develop
clinic
symptom
consist
rat
infect
increas
clinic
score
compar
anim
expos
uvinactiv
fig
note
signific
differ
clinic
eae
score
group
untreat
rat
compar
rat
treat
uvinactiv
group
receiv
encephalitogen
lymphocyt
eg
fig
experi
control
demonstr
antigenspecif
natur
eae
induct
sever
group
rat
use
includ
group
infect
receiv
encephalitogen
lymphocyt
rat
given
normal
conaactiv
lymphocyt
eg
fig
experi
detect
neurolog
symptom
observ
control
group
addit
assess
clinic
diseas
decreas
bodi
weight
follow
rat
expos
uvinactiv
infect
administ
encephalitogen
lymphocyt
induc
eae
fig
show
increas
weight
loss
two
timepoint
postinfect
compar
rat
expos
uvinactiv
asterisk
indic
signific
differ
p
x
compar
rat
versu
rat
expos
uvinactiv
comparison
panel
experi
show
induct
eae
rat
given
encephalitogen
lymphocyt
treat
uv
close
triangl
addit
panel
experi
show
lack
clinic
symptom
rat
given
normal
conaactiv
lymphocyt
close
triangl
two
experi
shown
repres
four
separ
studi
fig
lewi
rat
infect
show
increas
weight
loss
passivetransferinduc
eae
group
lewi
rat
expos
uvinactiv
infect
day
postinfect
rat
receiv
encephalitogen
lymphocyt
passiv
administr
via
tailvein
inject
follow
administr
encephalitogen
lymphocyt
rat
weigh
daili
basi
result
present
mean
percent
decreas
bodi
weight
standard
deviat
indic
time
postimmun
asterisk
indic
signific
differ
p
x
compar
rat
versu
rat
expos
uvinactiv
fig
lewi
rat
infect
show
increas
clinic
score
follow
highdos
administr
encephalitogen
lymphocyt
group
lewi
rat
expos
uvinactiv
close
squar
infect
close
circl
day
postinfect
indic
arrow
rat
receiv
encephalitogen
lymphocyt
passiv
administr
via
tailvein
inject
follow
administr
encephalitogen
lymphocyt
rat
monitor
daili
blind
fashion
presenc
clinic
symptom
result
present
mean
clinic
score
standard
deviat
indic
time
postimmun
asterisk
indic
signific
differ
p
x
compar
rat
versu
rat
expos
uvinactiv
sever
clinic
symptom
manipul
lewi
rat
model
vari
number
encephalitogen
lymphocyt
inject
therefor
studi
group
rat
expos
uvinactiv
infect
given
encephalitogen
lymphocyt
fig
show
anim
given
higher
number
encephalitogen
lymphocyt
progress
rapidli
moribund
state
howev
rat
infect
higher
initi
score
anim
expos
uvinactiv
fig
thu
regardless
protocol
use
abil
exacerb
clinic
diseas
consist
use
protocol
allow
rat
recov
fig
use
protocol
rat
rapidli
progress
moribund
state
fig
show
rat
significantli
higher
clinic
score
eae
fig
lewi
rat
latent
infect
display
increas
clinic
score
passivetransferinduc
eae
group
lewi
rat
expos
uvinactiv
close
squar
infect
close
circl
day
postinfect
indic
arrow
rat
receiv
encephalitogen
lymphocyt
passiv
administr
via
tailvein
inject
follow
administr
encephalitogen
lymphocyt
rat
monitor
daili
blind
fashion
presenc
clinic
symptom
result
present
mean
clinic
score
standard
deviat
indic
time
postimmun
asterisk
indic
signific
differ
p
x
compar
rat
versu
rat
expos
uvinactiv
studi
perform
twice
similar
result
fig
absenc
detect
viral
dna
cn
lewi
rat
undergo
clinic
eae
group
lewi
rat
expos
uvinactiv
infect
indic
within
latter
group
rat
nontreat
eae
rat
administ
encephalitogen
cell
induc
eae
eae
indic
rat
expos
uvinactiv
infect
without
eae
induct
kill
day
postinfect
repres
peak
leukocytosi
rat
infect
administ
encephalitogen
cell
induc
eae
kill
day
postinfect
rat
clinic
score
rat
kill
tissu
spleen
spinal
cord
taken
dna
extract
pcr
amplifi
gene
encod
number
pcr
cycl
use
amplif
indic
result
present
amplifi
pcr
product
electrophores
ethidiumbromidestain
agaros
gel
studi
perform
twice
similar
result
sjl
mous
fig
lewi
rat
fig
model
experiment
design
demonstr
exacerb
eae
rodent
begin
leukocytosi
clinic
symptom
progress
howev
upon
resolut
mononucleosislik
acutephas
diseas
splenomegali
resolv
remain
latent
leukocyt
question
whether
rat
latent
infect
also
increas
clinic
score
follow
passiv
administr
encephalitogen
cell
studi
group
rat
expos
uvinactiv
infect
allow
recov
acut
infect
splenomegali
time
postinfect
rat
viral
genom
present
latent
viru
splenic
leukocyt
detect
plaqueform
viru
tissu
homogen
day
postinfect
encephalitogen
lymphocyt
given
intraven
rat
score
daili
develop
clinic
symptom
consist
rat
latent
infect
increas
clinic
score
compar
anim
expos
uvinactiv
fig
address
possibl
sensit
nest
pcr
procedur
perform
detect
presenc
dna
encod
spleen
spinal
cord
infect
rat
infect
rat
undergo
clinic
eae
fig
show
result
one
pcr
viral
genom
easili
detect
peripher
lymphoid
organ
ie
spleen
spinal
cord
infect
rat
nest
pcr
perform
cycl
dna
could
detect
spinal
cord
wherea
viral
dna
sequenc
abund
spleen
use
pcr
cycl
similar
result
found
nest
pcr
perform
use
frontal
cortex
cerebellum
data
shown
although
qualit
differ
viralgenom
presenc
cn
versu
peripher
lymphoid
organ
suggest
minim
viral
replic
occur
cn
addit
plaqueform
assay
consist
fail
demonstr
presenc
lytic
viru
tissu
homogen
brain
spinal
cord
infect
rat
undergo
clinic
eae
regardless
timepoint
chosen
analysi
togeth
result
strongli
suggest
exacerb
eae
lewi
rat
model
due
signific
replic
viru
cn
recent
epidemiolog
studi
previou
investig
postul
associ
develop
andor
sever
ms
infect
gammaherpesviru
ebv
necess
reli
analys
use
antiebv
antibodi
patient
sera
cn
tissu
obtain
autopsi
provid
intrigu
correl
definit
result
present
studi
two
differ
rodent
model
eae
use
assess
abil
gammaherpesviru
infect
rodent
exacerb
neurolog
symptom
use
immunizationinduc
eae
sjl
mice
fig
passivetransferinduc
eae
lewi
rat
fig
overal
result
qualit
rodent
infect
significantli
moresever
clinic
diseas
rat
expos
uvinactiv
limit
abil
enter
cn
fig
lack
replic
latent
viru
fig
provid
import
focu
begin
understand
mechan
involv
virusinduc
exacerb
eae
certain
virus
includ
theiler
viru
murin
hepat
viru
inject
directli
cn
mice
caus
inflamm
demyelin
resembl
mslike
diseas
thu
preced
certain
virus
replic
within
cn
induc
patholog
clinic
symptomolog
describ
eae
howev
highli
unlik
base
result
present
result
other
directli
invad
cn
signific
extent
follow
peripher
infect
numer
laboratori
use
model
investig
great
detail
pathophysiolog
gammaherpesviru
infect
none
report
neurolog
symptom
acut
latent
phase
thu
infect
peripheri
result
eae
discern
clinic
symptomolog
addit
viral
genom
found
within
cn
infect
rodent
even
sensit
nest
pcr
procedur
use
fig
lack
signific
viral
burden
cn
argu
strongli
destruct
neuron
glial
cell
enter
cn
signific
extent
mechan
requir
exacerb
eae
must
occur
peripher
tissu
recent
discoveri
suggest
intrigu
possibl
understand
gammaherpesvirus
might
contribut
sever
autoimmun
diseas
molecular
mimicri
viral
protein
sequenc
encephalitogen
epitop
propos
gammaherpesviru
ebv
one
studi
found
viral
protein
could
activ
lymphocyt
specif
myelin
basic
protein
sjl
mice
anoth
recent
studi
found
particular
cell
receptor
ms
patient
recogn
myelinbasicprotein
peptid
peptid
deriv
ebv
protein
theoret
molecular
mimicri
could
lead
exagger
induct
activ
andor
differenti
encephalitogen
cell
therebi
augment
develop
sever
ms
howev
investig
contribut
molecular
mimicri
develop
autoimmun
diseas
ebv
infect
challeng
problem
inher
limit
human
experiment
fact
encephalitogen
epitop
might
differ
rodent
men
make
difficult
conclus
prove
molecular
mimicri
mechan
ebvexacerb
ms
fortun
genom
sequenc
therefor
possibl
exploit
inform
identifi
like
encephalitogen
epitop
importantli
use
experiment
model
definit
prove
whether
sequenc
involv
induc
increas
sever
eae
second
mechan
could
contribut
observ
exacerb
eae
would
one
depend
upon
antigen
crossreact
epitop
gammaherpesviru
caus
uniqu
dysregul
host
immun
respons
character
immunolog
disson
expans
b
lymphocyt
occur
mononucleosislik
phase
diseas
larg
specif
viral
antigen
fact
lymphocyt
infect
therefor
mechan
lead
cell
expans
must
requir
interact
input
cell
popul
possibl
mechan
involv
dysregul
host
lymphocyt
respons
follow
viral
infect
also
involv
augment
number
activ
encephalitogen
lymphocyt
present
develop
eae
note
howev
necessari
rat
experienc
peak
leukocytosi
exacerb
clinic
eae
fig
rat
latent
low
level
replic
viru
littl
splenomegali
rel
normal
number
percentag
lymphocyt
encephalitogen
lymphocyt
passiv
transfer
rat
exacerb
clinic
score
still
observ
result
signific
sinc
essenti
patient
develop
ms
latent
ebv
infect
acut
mononucleosi
ongo
studi
aim
defin
whether
encephalitogen
event
result
develop
eae
also
serv
stimulu
reactiv
latent
product
peripher
infect
case
suppress
viral
replic
prior
clinic
diseas
might
prove
effect
limit
sever
durat
damag
cn
highli
unlik
gammaherpesvirus
directli
caus
ms
eae
greater
world
popul
latent
infect
ebv
small
percentag
individu
develop
clinic
ms
therefor
assert
ebv
etiolog
agent
neurodegen
diseas
met
much
skeptic
like
possibl
could
help
explain
epidemiolog
experiment
data
would
role
ebv
environment
factor
may
exacerb
diseas
patient
rodent
predispos
develop
autoimmunemedi
demyelin
whether
virusinduc
exacerb
involv
molecular
mimicri
dysregul
leukocyt
function
clear
howev
studi
present
clearli
demonstr
peripher
infect
capabl
augment
inflammatori
respons
cn
rodent
model
viral
infect
extrem
valuabl
dissect
mechan
respons
gammaherpesvirusmedi
exacerb
autoimmun
diseas
propag
isol
previous
describ
intranas
inocul
perform
femal
sjl
mice
jackson
laboratori
bar
harbor
usa
femal
lewi
rat
charl
river
laboratori
wilmington
usa
previous
describ
group
sjl
mice
expos
uvinactiv
infect
day
prior
initi
immun
protocol
immun
protocol
similar
previous
report
involv
initi
inject
g
plp
peptid
emulsifi
complet
freund
adjuv
contain
mycobacteria
addit
mice
receiv
ng
bordetella
pertussi
toxin
research
biochem
intern
natick
usa
time
immun
day
postimmun
mice
expos
uvinactiv
infect
code
assess
daili
develop
eae
blind
fashion
use
follow
scale
evid
diseas
limp
tail
hind
limb
weak
limp
tail
hind
limb
weak
hind
limb
paralysi
moribund
sever
control
group
sjl
mice
infect
given
complet
freund
adjuv
alon
b
pertussi
toxin
alon
immun
irrelev
peptid
amino
acid
sequenc
hsfncggeffi
use
immun
scheme
ident
one
describ
passiv
administr
encephalitogen
lymphocyt
lewi
rat
use
second
rodent
model
eae
perform
previous
describ
encephalitogen
cell
line
establish
immun
lewi
rat
encephalitogen
peptid
myelin
basic
protein
previous
describ
group
lewi
rat
untreat
expos
uvinactiv
infect
intranas
pfu
indic
time
postinfect
eae
induc
rat
tailvein
inject
indic
number
encephalitogen
lymphocyt
anim
expos
uvinactiv
x
pfu
per
rat
use
control
rat
expos
uvinactiv
rat
code
assess
daili
develop
eae
blind
fashion
use
follow
scale
evid
diseas
flaccid
tail
hind
limb
paralysi
lowerbodi
paralysi
moribund
confirm
antigenspecif
natur
model
control
group
rat
receiv
conaactiv
leukocyt
expand
nonimmun
lewi
rat
presenc
dna
encod
spleen
spinal
cord
brain
rodent
detect
sensit
nest
pcr
protocol
previous
describ
presenc
lytic
viru
quantifi
previous
describ
use
plaqueform
assay
presenc
latent
viru
quantifi
use
infectiouscent
assay
previous
describ
day
postimmun
group
mice
infect
expos
uvinactiv
viru
kill
fivemicromet
section
spinal
cord
cerebellum
stain
use
hematoxylin
eosin
score
inflamm
previous
describ
signific
differ
mean
score
assess
use
mannwhitney
ttest
nonparametr
valu
student
ttest
appropri
result
determin
significantli
differ
p
x
